GLP-1 Drug Stocks Earnings Calendar

GLP-1 Drug Stocks Earnings Calendar tracks scheduled quarterly earnings releases, financial results webcasts, and investor conference calls for the publicly traded pharmaceutical companies developing or marketing GLP-1 receptor agonists, the drug class behind Ozempic, Wegovy, Mounjaro, and Zepbound. The calendar follows companies that meet a membership criterion of having a marketed product or a Phase 2 or later pipeline candidate in the GLP-1 receptor agonist class as of the most recent pipeline disclosure. The main names are Eli Lilly and Company, Novo Nordisk, Pfizer, Amgen, and Roche, whose common shares or American depositary receipts trade on the New York Stock Exchange, Nasdaq, and over-the-counter markets. Each company reports on its own financial calendar, with quarterly releases typically concentrated in late January, late April, late July, and late October. Each entry in the calendar is a single earnings event: a quarterly earnings release, a financial results announcement, or an accompanying conference call and webcast. Upcoming Q1 2026 entries include Eli Lilly and Company's release from Indianapolis, Indiana, followed by an online financial results conference call; Amgen's release from Thousand Oaks, California, with its earnings conference call; Pfizer's quarterly corporate performance webcast; and Novo Nordisk's financial results announcement and conference call, reflecting the company's headquarters in Denmark. Roche, headquartered in Basel, Switzerland, enters the calendar when its half-year or annual results coincide with pipeline updates for its GLP-1 candidates. Time zones vary by company and venue, with U.S.-listed names reporting around morning or afternoon Eastern Time and European names reporting in Central European Time. Equity research analysts, healthcare sector portfolio managers, and financial journalists who track the GLP-1 drug class can use this smart calendar feed — free to subscribe — to keep upcoming earnings dates and webcast times visible in Apple Calendar, Google Calendar, or Outlook. The feed helps finance professionals coordinate catalyst tracking around regulatory submissions, trial readouts, and quarterly updates without maintaining separate spreadsheets. Because the major GLP-1 developers often move together on clinical and pricing news, having a single calendar that marks the release and call separately creates a cleaner sequence than a ticker-only earnings list. The calendar updates regularly so rescheduled release times, revised webcast locations, and newly announced earnings dates appear automatically. Earnings dates in this finance calendar may be confirmed or estimated and can change; a quarterly release that shifts by a few days or a conference call that moves to a different time slot should not require manual correction in the subscriber's calendar app.